100 Participants Needed

ACB + IPACK Block for Pain Relief

LJ
Overseen ByLaith Jazrawi, MD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

What data supports the effectiveness of the treatment Adductor Canal Block and IPACK Block for pain relief?

Research shows that combining Adductor Canal Block (ACB) and IPACK Block can provide effective pain relief after knee surgery, especially for the back of the knee, without affecting muscle strength. This combination is as effective as other pain relief methods used after knee surgery.12345

Is the combination of Adductor Canal Block and IPACK Block generally safe for pain relief in humans?

The combination of Adductor Canal Block (ACB) and IPACK Block is generally considered safe for pain relief, as studies show it provides effective pain control without affecting muscle strength or causing significant side effects.12346

How is the ACB + IPACK block treatment different from other treatments for pain relief after knee surgery?

The ACB + IPACK block treatment is unique because it combines two types of nerve blocks to provide pain relief after knee surgery. The adductor canal block (ACB) targets the front of the knee, while the IPACK block focuses on the back of the knee, offering comprehensive pain control without affecting muscle strength, which helps patients move more easily after surgery.12346

What is the purpose of this trial?

A randomized, single-blind, single-center study measuring the effects of adductor canal block combined with IPACK infiltration compared to adductor canal block alone on post-operative pain and opioid consumption in patients undergoing high tibial osteotomy (HTO)/distal femoral osteotomy (DFO)/tibial tubercle osteotomy (TTO).

Research Team

LJ

Laith Jazrawi, MD

Principal Investigator

NYU Langone Health

Eligibility Criteria

This trial is for patients aged 18-75 undergoing high tibial, distal femoral, or tibial tubercle osteotomy with low risk of complications (ASA I or II). Excluded are those with chronic pain and opioid use, allergies to oxycodone, additional knee procedures, extreme obesity (BMI over 45), cognitive issues, substance abuse history, severe organ disease, inability to follow instructions or pregnant women.

Inclusion Criteria

I am undergoing leg realignment surgery.
I am in good or mild systemic disease condition.

Exclusion Criteria

I have been using opioids for chronic pain for over 3 months.
Patients who are allergic to oxycodone
I am having surgery on my cartilage or ACL.
See 10 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either an isolated adductor canal block or an adductor canal block combined with IPACK infiltration to manage post-operative pain

1 week
Daily visits during the first week post-operation

Follow-up

Participants are monitored for pain and opioid consumption, with assessments at various post-operative days and a 6-month follow-up

6 months
Multiple visits including POD 1, POD 2, POD 3, POD 7, and Month 6

Treatment Details

Interventions

  • Adductor Canal Block
  • IPACK Block
Trial Overview The study compares the effectiveness of two pain relief methods after leg bone surgery: one group receives an adductor canal block combined with IPACK infiltration while another gets only the adductor canal block. It's a randomized trial focusing on post-op pain and opioid use.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Adductor Canal Block (ACB) + IPACK BlockExperimental Treatment2 Interventions
Participants receive ACB with IPACK block.
Group II: Isolated Adductor Canal BlockActive Control1 Intervention
Participants receive ACB only.

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

Findings from Research

In a study of 120 patients undergoing total knee arthroplasty, the combination of adductor canal block (ACB) and interspace between popliteal artery and capsule of posterior knee block (IPACK) provided significantly better pain relief compared to ACB alone, as measured by VAS scores.
Patients receiving the ACB+IPACK technique also demonstrated improved range of motion and ambulation distance post-surgery, indicating that this method enhances recovery without compromising motor function.
Comparison of adductor canal block and IPACK block (interspace between the popliteal artery and the capsule of the posterior knee) with adductor canal block alone after total knee arthroplasty: a prospective control trial on pain and knee function in immediate postoperative period.Sankineani, SR., Reddy, ARC., Eachempati, KK., et al.[2022]
The combination of adductor canal block (ACB) with iPACK block provides noninferior pain relief compared to ACB with periarticular injection (PAI) after total knee arthroplasty, as shown in a study of 76 patients.
However, patients receiving the ACB + iPACK block required significantly more morphine and experienced greater reductions in quadriceps strength immediately after surgery, indicating potential trade-offs in functional performance.
Adductor Canal Block Combined With iPACK (Interspace Between the Popliteal Artery and the Capsule of the Posterior Knee) Block vs Periarticular Injection for Analgesia After Total Knee Arthroplasty: A Randomized Noninferiority Trial.Kertkiatkachorn, W., Kampitak, W., Tanavalee, A., et al.[2021]
In a study of 70 patients undergoing arthroscopic knee surgeries under spinal anesthesia, those who received an adductor canal block (ACB) experienced significantly lower morphine consumption (8.63 mg) compared to those who did not receive the block (21.91 mg), indicating ACB's effectiveness in pain management.
The ACB not only prolonged the duration of analgesia (approximately 366 minutes vs. 150 minutes) but also resulted in lower pain scores during rest and knee flexion, while maintaining better hemodynamic stability and showing no complications.
Evaluation of Analgesic Efficacy of Ultrasound-Guided Adductor Canal Block With 20 mL of 0.5% Ropivacaine in Patients Undergoing Knee Surgeries-A Randomized Control Trial.Arumugam, P., Ravi, S., Ln, S., et al.[2023]

References

Comparison of adductor canal block and IPACK block (interspace between the popliteal artery and the capsule of the posterior knee) with adductor canal block alone after total knee arthroplasty: a prospective control trial on pain and knee function in immediate postoperative period. [2022]
Adding Dexamethasone to Adductor Canal Block Combined With iPACK Block Improve Postoperative Analgesia of Total Knee Arthroplasty. [2022]
Adductor Canal Block Combined With iPACK (Interspace Between the Popliteal Artery and the Capsule of the Posterior Knee) Block vs Periarticular Injection for Analgesia After Total Knee Arthroplasty: A Randomized Noninferiority Trial. [2021]
4.China (Republic : 1949- )pubmed.ncbi.nlm.nih.gov
Evaluation of Analgesic Efficacy of Ultrasound-Guided Adductor Canal Block With 20 mL of 0.5% Ropivacaine in Patients Undergoing Knee Surgeries-A Randomized Control Trial. [2023]
A randomised controlled trial comparing adductor canal block and femoral nerve block for knee arthroplasty. [2020]
Adductor Canal Block Combined With IPACK Block for Postoperative Analgesia and Function Recovery Following Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Study. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security